Petri
Last updated:
Investment Thesis
Petri develops pre-seed companies attacking the world's largest problems at the frontier of biology and engineering, believing the future of biotech is founder-led.
Investment Profile
- Stage: Pre-Seed, Seed
- Sectors: Biotech, Bioengineering, Synthetic Biology, Food Tech
- Geography: US
Investment Team
- Jamie Goldstein — Founding/Managing Partner
- Russ Wilcox — CEO, Trellis Air & Venture Partner
- Tony Kulesa — Partner
Frequently Asked Questions
What does Petri invest in?
Petri is a pre-seed, seed stage Biotech, Bioengineering, Synthetic Biology, Food Tech investor, primarily investing in US. Their thesis: Petri develops pre-seed companies attacking the world's largest problems at the frontier of biology and engineering, believing the future of biotech is founder-led.
How do I get a meeting with Petri?
Use DryPowder's AI fund matching to see exactly how your startup aligns with Petri's thesis and portfolio. The tool gives you a fit score and specific talking points tailored to Petri's focus areas (Biotech, Bioengineering, Synthetic Biology, Food Tech), so you can approach them with confidence.
Is Petri actively deploying capital?
DryPowder tracks deployment signals for Petri — including recent deals, LP closes, and portfolio news. Signal subscribers get real-time alerts when Petri makes moves, so you can reach out when the timing is right.
Is Petri right for your startup?
Use DryPowder's AI fund matching to see how Petri compares to your raise profile — and find the best-fit investors from 500+ tracked funds.